Loading…
MOVICOL EASE is a brand name for Sodium Bicarbonate. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: For the relief of occasional constipation.
Verbatim from this product's MHRA label. Tap a section to expand.
Posology Do not use for more than 5 days. If constipation needs treatment for longer than 5 days, a doctor or pharmacist should be consulted. As for all laxatives, prolonged use is not recommended. Adults 18 years and over: 1-3 sachets daily in divided doses, according to individual response.
Once regularity in bowel movements has been restarted, dosage should be reduced and treatment can usually be stopped.
Children (below 18 years old):
Not recommended. Alternative Movicol products are available for children.
Patients with renal insufficiency:
No dosage change is necessary for treatment constipation. Method of administration Each sachet should be dissolved in 125ml water.
8. g. oedema, shortness of breath, increasing fatigue, dehydration, cardiac failure), Movicol Ease should be stopped immediately, medical advice should be sought, electrolytes should be measured, and any abnormality should be treated appropriately.
5). 3% of the WHO recommended maximum daily intake for sodium. When used long term for constipation, the maximum daily dose of this product is equivalent to 28% of the WHO recommended maximum daily intake for sodium. Movicol Ease is considered high in sodium.
This should be particularly taken into account for those on a low salt diet. 5. 5 Interaction with other medicinal products and other forms of interaction Macrogol raises the solubility of medicinal products that are soluble in alcohol and relatively insoluble in water.
4). g. anti-epileptics. Therefore, other medicines should not be taken orally for one hour before, during and for one hour after taking Movicol Ease. Movicol Ease may result in a potential interactive effect if used with starch-based food thickeners.
The Macrogol ingredient counteracts the thickening effect of starch, effectively liquefying preparations that need to remain thick for people with swallowing problems. 6 Fertility, pregnancy and lactation Pregnancy There are limited amount of data from the use of Movicol Ease in pregnant women.
3). Clinically, no effects during pregnancy are anticipated, since systemic exposure to macrogol 3350 is negligible. Movicol Ease can be used during pregnancy. Breastfeeding No effects on the breastfed newborn/infant are anticipated since the systemic exposure of the breast-feeding woman to Macrogol 3350 is negligible.
Movicol Ease can be used during breast-feeding. Fertility There are no data on the effects of Movicol Ease on fertility in humans. 3). 7 Effects on ability to drive and use machines Movicol Ease has no influence on the ability to drive and use machines.
Movicol Ease should not be used in children or adolescents under the age of 18 years. Prolonged excessive use may lead to fluid and electrolyte imbalance and hypokalaemia. Patients with kidney disorders should be aware of possible electrolyte imbalance.
Intestinal loss of fluids may promote dehydration. Symptoms may include thirst and oliguria. g. renal insufficiency, elderly patients) Movicol Ease should be discontinued and only be restarted under medical supervision. g. abdominal pain, nausea and vomiting, unless advised by a doctor, because these symptoms can be sign of potential or existing intestinal blockage (ileus).
Do not exceed the stated dose. The fluid content of Movicol Ease when re-constituted with water does not replace regular fluid intake and adequate fluid intake must be maintained. 8. g. oedema, shortness of breath, increasing fatigue, dehydration, cardiac failure), Movicol Ease should be stopped immediately, medical advice should be sought, electrolytes should be measured, and any abnormality should be treated appropriately.
5). 3% of the WHO recommended maximum daily intake for sodium. When used long term for constipation, the maximum daily dose of this product is equivalent to 28% of the WHO recommended maximum daily intake for sodium. Movicol Ease is considered high in sodium.
This should be particularly taken into account for those on a low salt diet. 5.
Intestinal perforation or obstruction due to structural or functional disorder of the gut wall, ileus, severe inflammatory conditions of the intestinal tract, such as Crohn's disease and ulcerative colitis and toxic megacolon. Hypersensitivity to the active substances.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Sodium Bicarbonate in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
8 Undesirable effects Reactions related to the gastrointestinal tract occur most commonly. These reactions may occur as a consequence of expansion of the contents of the gastrointestinal tract, and an increase in motility due to the pharmacologic effects of Movicol Ease.
Mild diarrhoea usually responds to dose reduction. The frequency of the adverse effects is not known as it cannot be estimated from the available data. System Organ Class Adverse Event Immune system disorders Allergic reactions, including anaphylactic reaction, dyspnoea, and skin reactions (see below).
Skin and subcutaneous tissue disorders Allergic skin reactions including angioedema, urticaria, pruritus, rash, erythema. Metabolism and nutrition disorders Electrolyte disturbances, particularly hyperkalaemia and hypokalaemia. Nervous system disorders Headache.
Gastrointestinal disorders Abdominal pain, diarrhoea, vomiting, nausea, dyspepsia, abdominal distension, borborygmi, flatulence and anorectal discomfort. General disorders and administration site conditions Peripheral oedema. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.